222 related articles for article (PubMed ID: 33478573)
1. Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.
Balzano-Nogueira L; Ramirez R; Zamkovaya T; Dailey J; Ardissone AN; Chamala S; Serrano-Quílez J; Rubio T; Haller MJ; Concannon P; Atkinson MA; Schatz DA; Triplett EW; Conesa A
Genome Biol; 2021 Jan; 22(1):39. PubMed ID: 33478573
[TBL] [Abstract][Full Text] [Related]
2. Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children.
Ziegler AG; Pflueger M; Winkler C; Achenbach P; Akolkar B; Krischer JP; Bonifacio E
J Autoimmun; 2011 Aug; 37(1):3-7. PubMed ID: 21376535
[TBL] [Abstract][Full Text] [Related]
3. Protocol for a nested case-control study design for omics investigations in the Environmental Determinants of Islet Autoimmunity cohort.
Oakey H; Giles LC; Thomson RL; Lê Cao KA; Ashwood P; Brown JD; Knight EJ; Barry SC; Craig ME; Colman PG; Davis EA; Hamilton-Williams EE; Harrison LC; Haynes A; Kim KW; Mallitt KA; McGorm K; Morahan G; Rawlinson WD; Sinnott RO; Soldatos G; Wentworth JM; Couper JJ; Penno MAS;
Ann Med; 2023 Dec; 55(1):2198255. PubMed ID: 37043275
[No Abstract] [Full Text] [Related]
4. The Environmental Determinants of Diabetes in the Young (TEDDY) Study: 2018 Update.
Rewers M; Hyöty H; Lernmark Å; Hagopian W; She JX; Schatz D; Ziegler AG; Toppari J; Akolkar B; Krischer J;
Curr Diab Rep; 2018 Oct; 18(12):136. PubMed ID: 30353256
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the development of islet autoantibodies through integration of environmental, genetic, and metabolic markers.
Webb-Robertson BM; Bramer LM; Stanfill BA; Reehl SM; Nakayasu ES; Metz TO; Frohnert BI; Norris JM; Johnson RK; Rich SS; Rewers MJ
J Diabetes; 2021 Feb; 13(2):143-153. PubMed ID: 33124145
[TBL] [Abstract][Full Text] [Related]
6. Integration of Infant Metabolite, Genetic, and Islet Autoimmunity Signatures to Predict Type 1 Diabetes by Age 6 Years.
Webb-Robertson BM; Nakayasu ES; Frohnert BI; Bramer LM; Akers SM; Norris JM; Vehik K; Ziegler AG; Metz TO; Rich SS; Rewers MJ
J Clin Endocrinol Metab; 2022 Jul; 107(8):2329-2338. PubMed ID: 35468213
[TBL] [Abstract][Full Text] [Related]
7. Association between vitamin D metabolism gene polymorphisms and risk of islet autoimmunity and progression to type 1 diabetes: the diabetes autoimmunity study in the young (DAISY).
Frederiksen BN; Kroehl M; Fingerlin TE; Wong R; Steck AK; Rewers M; Norris JM
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1845-51. PubMed ID: 23979957
[TBL] [Abstract][Full Text] [Related]
8. Age at Seroconversion, HLA Genotype, and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
Bauer W; Veijola R; Lempainen J; Kiviniemi M; Härkönen T; Toppari J; Knip M; Gyenesei A; Ilonen J
J Clin Endocrinol Metab; 2019 Oct; 104(10):4521-4530. PubMed ID: 31120497
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional networks in at-risk individuals identify signatures of type 1 diabetes progression.
Xhonneux LP; Knight O; Lernmark Å; Bonifacio E; Hagopian WA; Rewers MJ; She JX; Toppari J; Parikh H; Smith KGC; Ziegler AG; Akolkar B; Krischer JP; McKinney EF
Sci Transl Med; 2021 Mar; 13(587):. PubMed ID: 33790023
[TBL] [Abstract][Full Text] [Related]
10. Evidence of stage- and age-related heterogeneity of non-HLA SNPs and risk of islet autoimmunity and type 1 diabetes: the diabetes autoimmunity study in the young.
Frederiksen BN; Steck AK; Kroehl M; Lamb MM; Wong R; Rewers M; Norris JM
Clin Dev Immunol; 2013; 2013():417657. PubMed ID: 24367383
[TBL] [Abstract][Full Text] [Related]
11. Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY).
Waugh K; Snell-Bergeon J; Michels A; Dong F; Steck AK; Frohnert BI; Norris JM; Rewers M
PLoS One; 2017; 12(4):e0174840. PubMed ID: 28380011
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the vitamin D receptor gene (VDR) and its interaction with protein tyrosine phosphatase, non-receptor type 2 gene (PTPN2) on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY).
Frederiksen B; Liu E; Romanos J; Steck AK; Yin X; Kroehl M; Fingerlin TE; Erlich H; Eisenbarth GS; Rewers M; Norris JM
J Steroid Biochem Mol Biol; 2013 Jan; 133():51-7. PubMed ID: 22960018
[TBL] [Abstract][Full Text] [Related]
13. Incomplete time-series gene expression in integrative study for islet autoimmunity prediction.
Tanvir Ahmed K; Cheng S; Li Q; Yong J; Zhang W
Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36513375
[TBL] [Abstract][Full Text] [Related]
14. A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion.
Bonifacio E; Krumsiek J; Winkler C; Theis FJ; Ziegler AG
Acta Diabetol; 2014; 51(3):403-11. PubMed ID: 24249616
[TBL] [Abstract][Full Text] [Related]
15. Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity.
Siljander HT; Hermann R; Hekkala A; Lähde J; Tanner L; Keskinen P; Ilonen J; Simell O; Veijola R; Knip M
Eur J Endocrinol; 2013 Oct; 169(4):479-85. PubMed ID: 23904276
[TBL] [Abstract][Full Text] [Related]
16. Metabolite-related dietary patterns and the development of islet autoimmunity.
Johnson RK; Vanderlinden L; DeFelice BC; Kechris K; Uusitalo U; Fiehn O; Sontag M; Crume T; Beyerlein A; Lernmark Å; Toppari J; Ziegler AG; She JX; Hagopian W; Rewers M; Akolkar B; Krischer J; Virtanen SM; Norris JM;
Sci Rep; 2019 Oct; 9(1):14819. PubMed ID: 31616039
[TBL] [Abstract][Full Text] [Related]
17. The environment and the origins of islet autoimmunity and Type 1 diabetes.
Eringsmark Regnéll S; Lernmark A
Diabet Med; 2013 Feb; 30(2):155-60. PubMed ID: 23252770
[TBL] [Abstract][Full Text] [Related]
18. Characterization of plasma lipidomics in adolescent subjects with increased risk for type 1 diabetes in the DiPiS cohort.
Andersson Svärd A; Kaur S; Trôst K; Suvitaival T; Lernmark Å; Maziarz M; Pociot F; Overgaard AJ;
Metabolomics; 2020 Oct; 16(10):109. PubMed ID: 33033923
[TBL] [Abstract][Full Text] [Related]
19. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
Christen U; Kimmel R
Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
[TBL] [Abstract][Full Text] [Related]
20. Peptide serum markers in islet autoantibody-positive children.
von Toerne C; Laimighofer M; Achenbach P; Beyerlein A; de Las Heras Gala T; Krumsiek J; Theis FJ; Ziegler AG; Hauck SM
Diabetologia; 2017 Feb; 60(2):287-295. PubMed ID: 27815605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
